These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8003844)

  • 1. Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause.
    Thiébaud D; Burckhardt P; Melchior J; Eckert P; Jacquet AF; Schnyder P; Gobelet C
    Osteoporos Int; 1994 Mar; 4(2):76-83. PubMed ID: 8003844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.
    Krieg MA; Seydoux C; Sandini L; Goy JJ; Berguer DG; Thiébaud D; Burckhardt P
    Osteoporos Int; 2001; 12(2):112-6. PubMed ID: 11303710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-dependent bone mineral density response to oral pamidronate and calcium in postmenopausal osteoporosis: a preliminary report.
    Barreira JC; Messina OD; Maldonado-Cocco JA; Roldan EJ
    Clin Rheumatol; 1997 Jun; 16(4):346-52. PubMed ID: 9259247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral density gain in vertebrae of osteoporotic women on oral pamidronate reverts a year after treatment discontinuance.
    Zanchetta JR; Plotkin H; Roldán EJ
    Calcif Tissue Int; 1996 Jul; 59(1):70-2. PubMed ID: 8661988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis.
    Morabito N; Gaudio A; Lasco A; Vergara C; Tallarida F; Crisafulli G; Trifiletti A; Cincotta M; Pizzoleo MA; Frisina N
    Osteoporos Int; 2003 Jul; 14(6):500-6. PubMed ID: 12750879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oral pamidronate in preventing bone loss in postmenopausal women.
    Lees B; Garland SW; Walton C; Ross D; Whitehead MI; Stevenson JC
    Osteoporos Int; 1996; 6(6):480-5. PubMed ID: 9116394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis.
    Thiébaud D; Burckhardt P; Kriegbaum H; Huss H; Mulder H; Juttmann JR; Schöter KH
    Am J Med; 1997 Oct; 103(4):298-307. PubMed ID: 9382122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis.
    Fromm GA; Vega E; Plantalech L; Galich AM; Mautalen CA
    Osteoporos Int; 1991 Jun; 1(3):129-33. PubMed ID: 1790400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous pamidronate in the treatment and prevention of osteoporosis.
    Chan SS; Nery LM; McElduff A; Wilmshurst EG; Fulcher GR; Robinson BG; Stiel JN; Gunton JE; Clifton-Bligh PB
    Intern Med J; 2004 Apr; 34(4):162-6. PubMed ID: 15086695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclic intravenous pamidronate in treatment of osteoporosis].
    Vujasinović-Stupar N; Pilipović N; Branković S
    Med Pregl; 2004; 57(11-12):545-50. PubMed ID: 16107000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial.
    Boutsen Y; Jamart J; Esselinckx W; Stoffel M; Devogelaer JP
    Calcif Tissue Int; 1997 Oct; 61(4):266-71. PubMed ID: 9312195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclical pamidronate infusions in postmenopausal osteoporosis.
    Peretz A; Body JJ; Dumon JC; Rozenberg S; Hotimski A; Praet JP; Moris M; Ham H; Bergmann P
    Maturitas; 1996 Aug; 25(1):69-75. PubMed ID: 8887311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent oral disodium pamidronate in established osteoporosis: a 2 year double-masked placebo-controlled study of efficacy and safety.
    Ryan PJ; Blake GM; Davie M; Haddaway M; Gibson T; Fogelman I
    Osteoporos Int; 2000; 11(2):171-6. PubMed ID: 10793877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis.
    Heijckmann AC; Juttmann JR; Wolffenbuttel BH
    Neth J Med; 2002 Sep; 60(8):315-9. PubMed ID: 12481878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous pamidronate on renal function, bone mineral metabolism and bone mass in patients with severe osteoporosis.
    Hernández MV; Peris P; Monegal A; Reyes R; Muxi A; Gifre L; Guañabens N
    Am J Med Sci; 2010 Mar; 339(3):225-9. PubMed ID: 20220332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.
    Stokkers PC; Deley M; Van Der Spek M; Verberne HJ; Van Deventer SJ; Hommes DW
    Scand J Gastroenterol; 2006 Feb; 41(2):200-4. PubMed ID: 16484125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosis.
    Orr-Walker B; Wattie DJ; Evans MC; Reid IR
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):87-92. PubMed ID: 9059563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.
    Gallacher SJ; Fenner JA; Anderson K; Bryden FM; Banham SW; Logue FC; Cowan RA; Boyle IT
    Thorax; 1992 Nov; 47(11):932-6. PubMed ID: 1465751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.